Tom Willis

Chief Executive Officer

Therapeutic Areas

Drug	Indication	Phase
Aventa Clinical Test	Cancer (Gene Fusions/Rearrangements)	Commercial
Cancer Genomics Research	Oncology Biomarker Discovery	Research
Epigenetics & Gene Regulation	Broad Disease Research	Research
Genome Assembly Service	Reference Genome Construction	Service